Aberrant overexpression, activation, and dimerization of the individual members of the HER family--comprised of EGFR (Epidermal Growth Factor Receptor 1)/HER1, HER2, HER3, and HER4--contribute both to aggressive tumor growth and poor patient prognosis [1]. The gene discussed is EGFR; the disease is neoplasm.